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Withania somnifera (L.) Dunal originates mainly from Northern and Southern India. Primarily the roots are used in 
the Ayurvedic medicine as tonic, sedative hypnotic, adstringent, diuretic, emetic, and aphrodisiac. In Europe, it is 
widely used in food supplements. Due to the many effects and uses of this plant, the analysis of the Withania 
somnifera and optimization of industrial processing is nowadays an important issue. In Europe W. frutescens is 
native, and may be interesting for industrial preparation due to its similar phytochemical profi le to W. somnifera. The 
point of our research was to develop an effective extraction and hydrolysis method of the Withania frutescens leaves 
to optimize the industrial processing.
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Withania somnifera (L.) Dunal (Solanaceae, Sanskrit name: Ashwaganda) originates mainly 
from the southern and northern regions of India. This medium sized evergreen bush is widely 
used in the Ayurvedic medicine for different purposes (MATSUDA et al., 2001; SANGWAN et al., 
2004; LAL et al., 2006). Due to its adaptogenic effects, Withania somnifera root is mostly 
used as general tonic to alleviate fatigue and support the physical and mental activity, which 
explains its botanically misleading name, Indian ginseng. The main compounds considered 
to be most important for the bioactivity of W. somnifera are the so-called withanolides. The 
fi rstly isolated and the most extensively examined withanolide is withaferin A, the main 
withanolide of W. somnifera.
Due to the widespread Ayurvedic use of the plant, the pharmacological properties of W. 
somnifera have been studied in detail. Neuroprotective and acetylcholinesterase inhibitory 
effects have been observed in animal experiments, whereas human studies confi rmed the 
anxiolytic effect of the W. somnifera ethanolic extract (KULKARNI & DHIR, 2008; BHATNAGAR 
et al., 2012). Further preclinical studies with withanolides revealed their antitumor, 
chemopreventive, and anti-infl ammatory effects (BUDHIRAJA et al., 2000). Although the level 
of evidence is not suffi cient to use Withania or its active constituents as medicine, the long-
standing application of the plant and the available experimental pharmacological data support 
its safe application. Therefore, Withania is available in several food supplements for its 
health-promoting effects.
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The bioactivities of the plant are mainly related to the withanolides, with withaferin A as 
the major representative of this group. For standardization of the commercial products, 
withaferin A is considered as marker compound. Due to the biological activities of this 
compound, effective industrial processing of Withania species and extraction of withaferin A 
from plant material have become of major interest. Optimization studies usually aim at the 
extraction of withanolide aglycons (SANGWAN et al., 2004; MIRZAJANI et al., 2010; SUMITHRADEVI 
et al., 2011). For this purpose, beside the traditionally applied roots, leaves may also be used 
due to their high withaferin A content (PRAVEEN et al., 2010). Although withanolides are 
present in the plant material in remarkable quantity, extraction and hydrolysis of their 
glycosides to obtain free withanolides, such as withanone or withanolide A, has not been 
studied systematically yet. W. frutescens, a species native to Spain, has not been studied 
chemically extensively so far, however, withanolides were reported as its biologically active 
components (EL BOUZIDI et al., 2013).
1. Materials and methods
The present study aimed at the optimization of an extraction and hydrolysis method for the 
isolation of withaferin A from crude W. frutescens extract. Withania frutescens (L.) Pauquy 
plant materials (leaves, twigs, and roots) were collected from 3 years old cultivated plants 
(Reading, UK) and from wild plants in Spain. For the optimization of extraction method 
leaves were used. From dried fi ne ground W. frutescens leaves 1–1 g was extracted with 
different solvents (10 ml) by ultrasonic bath under tempered circumstances (25 °C) for 10 
min. The extracts were evaporated to dryness with the help of rotation evaporator (300 mBar, 
40 °C) and the dry masses were measured. Immediately after the evaporation, the dry extracts 
were dissolved in methanol and fi ltered through 0.45 μm PTFE syringe membrane fi lters, 
then analysed with HPLC. For the HPLC analysis, Kinetex 150×4.6 mm, 5μ, RP C-18 column 
was used on a Waters 600 HPLC system equipped with a DAD detector. Gradient elution was 
carried out with H2O–MeOH–EtOH (0 min: 65:17.5:17.5, 25 min: 55:22.5:22.5, 40 min: 
0:50:50 ratio; 1 ml min–1, detected at 230 nm). The peak of withaferin A was detected at 10 
min (withaferin A standard has been purchased from Sigma-Aldrich, purity of 95.0%). The 
comparison of HPLC chromatograms of different extracts is presented in Figure 1. The 
withaferin A content of twigs (6 samples), leaves (4 samples), and roots (8 samples) was 
measured by the method described above, using 10 ml of MeOH–H2O 1:1 as extracting 
solvent. During the hydrolysis experiments, 0.5 g of Withania leaf extract (prepared with 
MeOH–H2O 1:1) was hydrolysed for 30 min at 100 °C with 20 ml of 10% phosphoric acid, 
acetic acid, sulphuric acid, and hydrochloric acid. The results of hydrolysis were monitored 
by TLC (normal phase, CH2Cl2–cyclohexane–MeOH 3.7:1:0.3, detection by spraying with 
vanillin–sulphuric acid followed by heating at 120 °C for 1 min).
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Fig. 1. HPLC comparison of various extracts. Extracting solvents: 1: CH2Cl2; 2: CH2Cl2–MeOH 75:25; 3: CH2Cl2–
MeOH 50:50; 4: CH2Cl2–MeOH 25:75; 5: MeOH; 6: MeOH–H2O 75:25; 7: MeOH–H2O = 50:50; 8: MeOH–H2O 
25:75; 9: EtOH; 10: CH2CL2–EtOH 25:75; 11: EtOH–H2O 75:25
2. Results and discussion
After the extensive extraction trial, the most effective extraction solvent proved to be MeOH–
H2O 1:1 (Table 1). The extract prepared with this solvent resulted in high dry mass and 
contained the highest amount of withaferin A. Extracts gained with MeOH and H2O contained 
also remarkable amounts of withanolide glycosides.
Table 1. Extraction of Withania frutescens leaf with different solvents
Extraction solvent Dry mass (mg) Withaferin A content 
(mg)
Percentage of 
withaferin A in dry 
mass (%)
CH2Cl2 100 9.62 1.72 17.88
CH2Cl2:MeOH 75:25 33.41 5.63 16.85
CH2Cl2:MeOH 50:50 58.08 7.88 13.57
CH2Cl2:MeOH 25:75 85.59 7.93 9.27
MeOH 100 69.54 7.68 11.04
MeOH:H2O 75:25 129.91 1.83 1.41
MeOH:H2O 50:50 140.70 20.44 14.52
MeOH:H2O 25:75 157.18 7.92 5.03
EtOH 100 76.90 2.39 3.11
CH2Cl2:EtOH 25:75 42.83 2.77 6.46
EtOH:H2O 75:25 70.18 5.78 8.24
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In the Ayurvedic medicine primarily the roots of W. somnifera are used. Taking into 
account that other plant parts may also contain withanolides, the withaferin A content of 
different plant parts of W. frutescens was also studied (Table 2).
Table 2. Average withaferin A content of plant organs, extracted with MeOH–H2O 1:1
Plant part Withaferin A content (mg g–1) Standard deviation (mg g–1)
Leaf 4.38 0.1678
Root 1.60 0.0638
Twig 1.53 0.0015
To enhance the effi ciency of withaferin A production from the plant material, a hydrolysis 
study was started. Initial tests (data not shown) revealed that hydrolysis was successful only 
with sulphuric acid and acetic acid, which were then further used for the optimization of the 
hydrolysis by modifying acid concentration and reaction time. Withaferin A contents of the 
hydrolysates were verifi ed by HPLC according to the method presented before. The 
parameters (hydrolysis time, acid concentration) and resulting withaferin A concentrations 
are listed in Table 3. The highest yield in free withaferin A was obtained with hydrolysing 
with sulphuric acid in concentration of 1% for 90 min.
Table 3. Hydrolysis experiments with a Withania frutescens leaf extract (MeOH–H2O 1:1)
Acid name C (V/V%) Time of sampling (min) Free withaferin A (mg)
Sulphuric acid 1.00 30 0.81
1.00 60 0.83
1.00 90 0.95
2.50 30 0.84
2.50 60 0.86
2.50 90 0.87
5.00 30 0.86
5.00 60 –
5.00 90 –
7.50 30 –
7.50 60 0.86
7.50 90 –
10.0 30 0.82
10.0 60 0.84
10.0 90 0.82
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Acid name C (V/V%) Time of sampling (min) Free withaferin A (mg)
Acetic acid 25 4 0.80
25 5 0.81
25 6 0.80
50 4 0.79
50 5 0.80
50 6 0.80
100 4 0.78
100 5 0.79
100 6 0.79
3. Conclusions
Our experiments revealed that leaves, twigs, and roots of W. frutescens contain remarkable 
amount of withaferin A. Based on the high withaferin A content (4.38 mg g–1), the high 
biomass production compared to twigs, and also considering the aspects of sustainable 
cultivation, leaves seem to be the most promising sources for industrial processing. To further 
increase the yield of withaferin A, we successfully developed an effective method to gain the 
withanolide-rich extracts from Withania frutescens leaf. Dichloromethane-containing 
extracting solvents resulted in withaferin A-rich extracts, however the overall yield of this 
compound could be maximized by using mixtures of methanol and water. Hydrolysis of 
extracts was also optimized in order to enhance the effi ciency of withaferin A production 
from plant material. This European species may be regarded as a perspective source for 
withanolide production.
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